| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_715946dfd122eb9277028d69e0cf56a3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate |
2008-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f7663624526b7ecfc2fa629e2963571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e51250eef4133abd1a29097af2c91286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e666b287c31cef1162717b3c26a9be61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14bc850c2df19fe6524d79635c7439a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80bdc3006b0b85822c0764d4cccd45e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8de746252ee4cca66d06bafa22419896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fedf15a76d51114ef6808a5081877cf8 |
| publicationDate |
2016-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3023436-A1 |
| titleOfInvention |
Improved methods for generation, labeling and use of mhc multimers |
| abstract |
The present invention describes novel methods to generate MHC multimers and methods to improve existing and new MHC multimers. The invention also describes improved methods for the use of MHC multimers in analysis of T-cells in samples including diagnostic and prognostic methods. Furthermore the use of MHC multimers in therapy are described, e.g. anti-tumour and anti-virus therapy, including isolation of antigen specific T-cells capable of inactivation or elimination of undesirable targeT-cells or isolation of specific T-cells capable of regulation of other immune cells. |
| priorityDate |
2007-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |